| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/29/2011 | US20110237782 Methods for glyco-engineering plant cells for controlled human o-glycosylation |
| 09/29/2011 | US20110237779 Cdr-repaired antibodies |
| 09/29/2011 | US20110237777 Fusion protein containing a single-stranded dna binding protein and methods for expression and purification of the same |
| 09/29/2011 | US20110237655 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 09/29/2011 | US20110237652 Detection and destruction of cancer cells using programmed genetic vectors |
| 09/29/2011 | US20110237647 Inhibitory rna for modulating the molecular function of zfat gene |
| 09/29/2011 | US20110237645 USE OF RNAi TECHNOLOGY TO INHIBIT ASIC3 |
| 09/29/2011 | US20110237523 CONTRACEPTIVE PEPTIDES DERIVED FROM THE VENOM OF THE SPIDER Latrodectus mirabilis, NUCLEOTIDE SEQUENCES TO TRANSFORM A MICROORGANISM TO PRODUCE SAID PEPTIDES; METHODS TO OBTAIN THE PEPTIDES; PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND USE THEREOF |
| 09/29/2011 | US20110237521 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| 09/29/2011 | US20110237518 Method for treating or preventing bladder cancer using the depdc1 polypeptide |
| 09/29/2011 | US20110237515 Peptide derived from neurotesin receptor 3 and use thereof in the treatment of psychiatric diseases |
| 09/29/2011 | US20110237514 PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES WHICH COMPRISES PROTEIN COMPRISING Frizzled1, Frizzled2 OR Frizzled7 EXTRACELLULAR CYSTEINE-RICH DOMAIN |
| 09/29/2011 | US20110237509 hGH AND METHODS FOR PREPARING hGH |
| 09/29/2011 | US20110237501 Detection of Mutations in a Gene Associated with Resistance to Viral Infection, OAS1 |
| 09/29/2011 | US20110237498 Soluble polypeptides for use in treating autoimmune and inflammatory disorders |
| 09/29/2011 | US20110237485 Chrysosporium Cellulase and Methods of Use |
| 09/29/2011 | US20110237459 Multiplexed Assay Using Encoded Solid Support Matrices |
| 09/29/2011 | US20110237451 Competitive n-hybrid system |
| 09/29/2011 | US20110237448 Carbohydrate binding module with affinity for insoluble xylan |
| 09/29/2011 | US20110236979 Apparatus for Generating Electrical Pulses and Methods of Using Same |
| 09/29/2011 | US20110236978 Reprogramming cells toward a pluripotent state |
| 09/29/2011 | US20110236977 Dental stem cell differentiation |
| 09/29/2011 | US20110236976 Vector comprising multiple homologous nucleotide sequences |
| 09/29/2011 | US20110236972 Nucleic acid compounds for inhibiting birc5 gene expression and uses thereof |
| 09/29/2011 | US20110236969 Methods of generating variant proteins with increased host string content and compositions thereof |
| 09/29/2011 | US20110236968 Humanized antibodies against monocyte chemotactic proteins |
| 09/29/2011 | US20110236967 Promiscuous her-2/neu cd4 t cell epitopes |
| 09/29/2011 | US20110236966 Single lentiviral vector system for induced pluripotent (ips) stem cells derivation |
| 09/29/2011 | US20110236956 MULTICISTRONIC siRNA CONSTRUCTS TO INHIBIT TUMORS |
| 09/29/2011 | US20110236955 Arylacylamidase gene and method of using the same |
| 09/29/2011 | US20110236935 Oxidation process |
| 09/29/2011 | US20110236933 RECOMBINANT EUKARYOTIC EXPRESSION PLASMID ENCODING pprI GENE OF DEINOCOCCUS RADIODURANS R1 AND ITS FUNCTIONS |
| 09/29/2011 | US20110236928 Methods for producing polypeptides in enzyme-deficient mutants of fusarium venenatum |
| 09/29/2011 | US20110236927 Genetically stabilized tandem gene duplication |
| 09/29/2011 | US20110236920 Novel variants of pqq-dependent glucose dehydrogenase having improved substrate specificity |
| 09/29/2011 | US20110236915 Zap-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (cll/sll) |
| 09/29/2011 | US20110236894 Selective oxidation of 5-methylcytosine by tet-family proteins |
| 09/29/2011 | US20110236886 Pathogenicity determinants which can be used as targets for developing means for preventing and controlling bacterial infections and/or systemic dissemination |
| 09/29/2011 | US20110236484 Genus-Wide Chlamydial Peptide Vaccine Antigens |
| 09/29/2011 | US20110236469 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 09/29/2011 | US20110236427 Antagonists of NR2F6 For Augmenting The Immune Response |
| 09/29/2011 | US20110236420 Bluetongue virus recombinant vaccines and uses thereof |
| 09/29/2011 | US20110236419 Recombinant cdv compositions and uses thereof |
| 09/29/2011 | US20110236418 Materials and Methods for Improved Vaccination |
| 09/29/2011 | US20110236416 Foot and mouth disease virus recombinant vaccines and uses thereof |
| 09/29/2011 | US20110236410 Klebsiella antigens |
| 09/29/2011 | US20110236407 Vaccine for runting-stunting syndrome |
| 09/29/2011 | US20110236397 Limited proteolysis of cd2ap and progression of renal disease |
| 09/29/2011 | US20110236394 Methods for the regulation of the prostaglandin f synthase (pgfs) activity of akr1b1 and uses thereof |
| 09/29/2011 | US20110236393 Monoclonal antibody production in b cells and uses therof |
| 09/29/2011 | US20110236390 IL-17A Antagonists |
| 09/29/2011 | US20110236389 Human Angiostatin Interacting and Tumor Metastasis Involving Protein Variants and Uses Thereof |
| 09/29/2011 | US20110236388 Bispecific, bivalent anti-vegf/anti-ang-2 antibodies |
| 09/29/2011 | US20110236380 Ligands that bind il-13 |
| 09/29/2011 | US20110236378 Non-human mammals for the production of chimeric antibodies |
| 09/29/2011 | US20110236375 Antibody variants with enhanced complement activity |
| 09/29/2011 | US20110236362 NKT CELL-DERIVED iPS CELLS AND NKT CELLS DERIVED THEREFROM |
| 09/29/2011 | US20110236353 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 09/29/2011 | US20110236339 Perhydrolase providing improved specific activity |
| 09/29/2011 | US20110236338 Perhydrolase providing improved specific activity |
| 09/29/2011 | US20110236337 Perhydrolase providing improved specific activity |
| 09/29/2011 | US20110236336 Perhydrolase providing improved specific activity |
| 09/29/2011 | US20110236335 Perhydrolase providing improved specific activity |
| 09/29/2011 | US20110236306 Compositions and methods for the removal of biofilms |
| 09/29/2011 | US20110232179 Grg23 epsp synthases: compositions and methods of use |
| 09/29/2011 | DE19641876B4 Streptavidinmuteine Streptavidin muteins |
| 09/29/2011 | DE112009001667T5 Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben Plants having enhanced yield-related traits and methods of making the same |
| 09/29/2011 | DE112009001459T5 Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben Plants having enhanced yield-related traits and methods of making the same |
| 09/29/2011 | DE102010013166A1 Verfahren zur Erhöhung des Samenertrages sowie Förderung des Wachstums von Pflanzen A method for increasing seed yield and promoting the growth of plants |
| 09/29/2011 | CA2831271A1 The isolation and use of fad2 and fae1 from camelina |
| 09/29/2011 | CA2794383A1 Adenovirus derived helper virus for enhancing recombinant parvovirus production |
| 09/29/2011 | CA2794359A1 Infectious hepatitis c virus-high producing hcv variants and use thereof |
| 09/29/2011 | CA2794244A1 Thermostable phytase variants |
| 09/29/2011 | CA2794199A1 Aptamer for ngf and use thereof |
| 09/29/2011 | CA2794187A1 Rna interference in ocular indications |
| 09/29/2011 | CA2794167A1 Bmp-7 peptides & methods of use |
| 09/29/2011 | CA2794165A1 Bmp-4 peptides & methods of use |
| 09/29/2011 | CA2794142A1 Materials and methods related to modulation of mismatch repair and genomic stability by mir-155 |
| 09/29/2011 | CA2794095A1 Thermostable phytase variants |
| 09/29/2011 | CA2794037A1 Modifying enzyme activity in plants |
| 09/29/2011 | CA2793959A1 Cmv glycoproteins and recombinant vectors |
| 09/29/2011 | CA2793906A1 Methods and compositions for the detection and identification of archaea based on the type ii chaperonin (thermosome) gene |
| 09/29/2011 | CA2793753A1 Antibodies to muc16 and methods of use thereof |
| 09/29/2011 | CA2793750A1 Method and compositions to induce apoptosis of tumoral cells expressing shh |
| 09/29/2011 | CA2791172A1 Plants having enhanced yield-related traits and method for making the same |
| 09/28/2011 | EP2369517A2 Methods for the identification of microrna and their applications in research and human health |
| 09/28/2011 | EP2369493A1 Gene network-based method for confirming drug action |
| 09/28/2011 | EP2369010A2 Nitrile hydratases from metagenome libraries |
| 09/28/2011 | EP2369009A2 Nitrile hydratases from metagenome libraries |
| 09/28/2011 | EP2369007A1 Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
| 09/28/2011 | EP2369005A1 Biological active proteins having increased in vivo and/or in vitro stability |
| 09/28/2011 | EP2369002A1 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs |
| 09/28/2011 | EP2369001A2 PRRS viruses, infectious clones, mutants thereof, and methods of use |
| 09/28/2011 | EP2369000A1 Production of peptides and proteins by accumulation in mitochondria |
| 09/28/2011 | EP2368999A1 Bone targeted alkaline phosphatase, kits and methods of use thereof |
| 09/28/2011 | EP2368998A1 RSV F protein and use of same |
| 09/28/2011 | EP2368997A2 Method for isolation of soluble polypeptides |
| 09/28/2011 | EP2368996A2 Method for isolation of soluble polypeptides |
| 09/28/2011 | EP2368995A2 Method for isolation of soluble polypeptides |
| 09/28/2011 | EP2368994A2 Method for isolation of soluble polypeptides |